Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology
Fabrizio Moro, Ugolino Livi
Topics & Concepts
MedicinePhosphodiesterasecGMP-specific phosphodiesterase type 5Coronavirus disease 2019 (COVID-19)PharmacologyUrologyInternal medicineChemistryEnzymeErectile dysfunctionDiseaseInfectious disease (medical specialty)BiochemistryCardiac, Anesthesia and Surgical OutcomesAnesthesia and Pain ManagementBlood Pressure and Hypertension Studies